To meet patient needs, reliable and cost-effective manufacturing processes are crucial. Yet, the complexity of scaling viral vector processes to commercial levels and the absence of standardized ...

Download this application note to receive step-by-step guidance about optimizing and standardizing scalable lentiviral vector production and clarification.

The popularity of viral vector-based gene therapies and vaccines is rapidly growing. However, it is often difficult for scientists to ramp up the generation of these vectors to meet their needs at ...

They engineered an adenoviral vector to include a repressor protein ... other advantages over alternative ‘helper-free’ rAAV manufacturing systems. “For all the serotypes tested, we ...

Novartis invested €40 million (US$43 million) into the facility, which is the company’s first specialized viral vector manufacturing facility in Europe (1). With this investment, Novartis ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a market size of USD 24.6 Billion by 2032 growing at a CAGR of 18.5% from ...

Signal Hound – manufacturer of accessible, versatile, precision test equipment – announced the release of the highly anticipated VNA400 to its expanding product line.